Semler Scientific (SMLR) Stock Price, News & Analysis

Company Overview

Semler Scientific, Inc. provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. It also offers Insulin Insights, a software program that is used by a healthcare provider to optimize outpatient insulin dosing. The company's products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, family practitioners, healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups and retailers. It offers its products through sales representatives and distributors. The company was incorporated in 2007 and is headquartered in Santa Clara, California.

Key Stats

• Today's Range: $23.16 to $24.55
• 50-Day Range: $23.49 to $36.21
• 52-Week Range: $20.88 to $53.38
• Volume: 230,975 shs
• Average Volume: 190,281 shs
• Market Capitalization: $163.08 million
• P/E Ratio: 8.36
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Strong Buy

Semler Scientific Stock Analysis - MarketRank™

Semler Scientific scored higher than 26% of companies evaluated by MarketBeat, and ranked 853rd out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Semler Scientific.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Semler Scientific is 8.43, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 137.32.

Price to Earnings Ratio vs. Sector

The P/E ratio of Semler Scientific is 8.43, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 143.28.

Price to Book Value per Share Ratio

Semler Scientific has a P/B Ratio of 2.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

13.75% of the float of Semler Scientific has been sold short.

Short Interest Ratio / Days to Cover

Semler Scientific has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Semler Scientific has recently decreased by 2.11%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Semler Scientific does not currently pay a dividend.

Dividend Growth

Semler Scientific does not have a long track record of dividend growth.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

13.75% of the float of Semler Scientific has been sold short.

Short Interest Ratio / Days to Cover

Semler Scientific has a short interest ratio ("days to cover") of 2.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Semler Scientific has recently decreased by 2.11%, indicating that investor sentiment is improving.

News and Social Media

• Score: 1.4 / 5
• News Sentiment: N/A

News Sentiment

Semler Scientific has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Semler Scientific this week, compared to 1 article on an average week.

MarketBeat Follows

Only 1 people have added Semler Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Semler Scientific insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $283,500.00 in company stock.

Percentage Held by Insiders

13.00% of the stock of Semler Scientific is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

49.37% of the stock of Semler Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SMLR Stock Analysis - Frequently Asked Questions

How have SMLR shares performed this year?

Semler Scientific's stock was trading at $44.29 at the beginning of the year. Since then, SMLR stock has decreased by 46.9% and is now trading at $23.53.
View the best growth stocks for 2024 here.

How were Semler Scientific's earnings last quarter?

Semler Scientific, Inc. (NASDAQ:SMLR) announced its earnings results on Monday, August, 5th. The company reported $0.64 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.56 by $0.08. The firm had revenue of $14.47 million for the quarter. Semler Scientific had a net margin of 25.62% and a trailing twelve-month return on equity of 21.17%.

Who are Semler Scientific's major shareholders?

Top institutional investors of Semler Scientific include AQR Capital Management LLC (1.97%), Dimensional Fund Advisors LP (1.78%), Acadian Asset Management LLC (1.64%) and Renaissance Technologies LLC (0.80%).
View institutional ownership trends.

How do I buy shares of Semler Scientific?

Shares of SMLR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/05/2024
• Today: 9/20/2024
• Next Earnings (Estimated): 11/14/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Electromedical equipment
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:SMLR
• CUSIP: N/A
• CIK: 1554859
• Web: www.semlerscientific.com
• Phone: 877-774-4211
• Fax: N/A
• Employees: 120
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $2.79
• Trailing P/E Ratio: 8.43
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $20.58 million
• Net Margins: 25.62%
• Pretax Margin: 30.34%
• Return on Equity: 21.17%
• Return on Assets: 19.40%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.72
• Quick Ratio: 3.66

Sales & Book Value

• Annual Sales: $68.18 million
• Price / Sales: 2.41
• Cash Flow: $2.85 per share
• Price / Cash Flow: 8.25
• Book Value: $10.45 per share
• Price / Book: 2.25

Miscellaneous

• Outstanding Shares: 6,990,000
• Free Float: 6,147,000
• Market Cap: $164.47 million
• Optionable: Not Optionable
• Beta: 0.96